Viewing nowGabanyuro Sustained-Release Tablet 150 mg (Pregabalin)
Pregabalin 70mg
Tablet · Prescription medication
Hanlim Pharmaceutical Co., Ltd.

MFDS item code 201900147 · Approved 2019.01.11 · Insurance code 645306000
Treatment of peripheral neuropathic pain in adults
This medication is used to relieve peripheral neuropathic pain in adults. Peripheral neuropathic pain is pain caused by nerve damage, which can significantly disrupt daily life. This drug helps improve symptoms by suppressing excessive nerve activity and reducing pain signals. Therefore, it effectively aids in lessening discomfort caused by peripheral neuropathic pain and plays an important role in improving the patient's quality of life.
This medicine should be administered once daily after the evening meal. It should be swallowed whole and should not be split, crushed, or chewed. A starting dose of 150 mg per day may be administered. Based on each patient's response and tolerability, the dose may be increased at weekly intervals to a maximum of 600 mg per day. Based on current clinical experience, if treatment with this medicine is discontinued, it should be tapered gradually, with intervals of at least 1 week. The safety and efficacy of this medicine have not been established in patients with renal impairment. The safety and efficacy of this medicine have not been established in patients with hepatic impairment. The safety and efficacy of this medicine have not been established in older adults aged 65 years or older.
The safety and efficacy of this medicine have not been established in pediatric and adolescent patients under 19 years of age.
This medication may increase the risk of suicidal thoughts and behaviors, so patients should be carefully monitored for signs of depression, mood changes, or abnormal behavior during treatment. Patients allergic to pregabalin or any ingredients in this medication should not use it. Diabetic patients may need to adjust the dosage of blood sugar control medication due to weight gain. If symptoms of angioedema occur, such as swelling of the face or around the mouth, discontinue use immediately and consult a healthcare professional. Elderly patients should take special care at the beginning of treatment due to the risk of falls or injury from dizziness or drowsiness. These symptoms should be reported to a healthcare professional, as blurred vision or vision changes may occur. Abrupt discontinuation of this medication may cause withdrawal symptoms such as insomnia, headache, nausea, and anxiety, so dosage should be gradually reduced according to a healthcare professional's instructions. Patients with a history of drug abuse may have a higher risk of abuse with this medication, thus caution is warranted. Patients with reduced kidney function may require dosage adjustments, and it should be administered cautiously to patients with severe heart failure. Concomitant use with opioid analgesics may increase the risk of central nervous system depression, so caution is advised. This medication should not be taken by pregnant women in early pregnancy due to the risk of congenital malformations in the fetus, and women of childbearing age should use effective contraception. Dizziness and drowsiness may occur during treatment, so it is advisable to avoid driving or operating hazardous machinery. Serious skin reactions may occur infrequently; if rashes or skin abnormalities appear, discontinue use immediately and consult a healthcare professional. In case of overdose, confusion, drowsiness, depression, seizures, etc., may occur, requiring immediate emergency treatment. This medication should be kept out of reach of children and should not be transferred to another container for safety.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to prevent air and moisture from entering. The storage temperature should be maintained at room temperature between 1 and 30 degrees Celsius.
White to slightly yellow oblong film-coated sustained-release tablet
30 tablets (6 tablets/PTP x 5)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowPregabalin 70mg
Tablet · Prescription medication
Hanlim Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 300mg
Hard capsule · Prescription medication
Viatris Korea Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Samjin Pharmaceutical Co., Ltd.

Pregabalin 75mg
Hard capsule · Prescription medication
Hanmi Pharm. Co., Ltd.

Pregabalin 150mg
Hard capsule · Prescription medication
Hanmi Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.